Board of Directors

Chairman of the Board
James M. Weaver

Mr. Weaver is Vice President of Alticor Corporate Enterprises, a member of the Alticor Inc. family of companies. He is responsible for managing the current portfolio of companies and directs all acquisition and growth. Prior to joining Alticor, Mr. Weaver worked for X-Rite Inc. holding numerous leadership positions including Senior Vice President and General Manager, Vice President of marketing and software development, Vice President of marketing and product development, and also was the lead executive on several acquisitions. Mr. Weaver also founded and held the position of President and Chief Executive Officer of Bold Furniture Inc, and has held various leadership roles at Steelcase Inc. and Bissell Inc. Mr. Weaver received a bachelor’s degree in general studies from the University of Michigan in Ann Arbor. He also completed a consumer marketing course at the Kellogg School of Management at Northwestern University in Evanston, Ill. He holds professional memberships in the American Marketing Association, the Product Development Management Association, and the Design Management Institute, and serves on several non-profit and private company boards. Mr. Weaver joined Interleukin Genetics September 2007 as Chairman of the Board.

Board Member
Kenneth S. Kornman, DDS, Ph. D.

Kenneth S. Kornman, DDS, Ph.D. is our Chief Executive Officer, co-founder, President and Chief Scientific Officer. Prior to founding the Company in 1986, Dr. Kornman was a Department Chairman and Professor at The University of Texas Health Center at San Antonio. He has also been a consultant and scientific researcher for many major oral care and pharmaceutical companies. Dr. Kornman currently holds an academic appointment at Harvard University. He holds multiple patents in the pharmaceutical area, has published three books and more than 100 scientific papers and has lectured and consulted worldwide on the transfer of technology to clinical practice. Dr. Kornman also holds an MS (Periodontics) and Ph.D. (Microbiology Immunology) from the University of Michigan.

Board Member
Mary E. Chowning

Mary E. Chowning served as Vice President, Chief Financial Officer and Secretary of X-Rite Inc., from July 28, 2003 to July 5, 2006. Ms. Chowning served as an Executive Vice President, Chief Financial Officer and Secretary of X-Rite Inc., from July 5, 2006 to March 3, 2008 and also served as its Principal Accounting Officer from July 28, 2003 to March 3, 2008. Prior to X-Rite, she co-founded the Wind River group of companies and served as its Managing Member, as well as its Chief Financial Officer for four years. Ms. Chowning began her career with Arthur Andersen LLP and spent 14 years in Public Accounting where she served in various positions of increasing responsibility with public and private clients in manufacturing, consumer products, technology and various service industries. She was made a Partner in the firm in 1996. Ms. Chowning is currently a member of the Board of Directors of Fincor Holdings, Inc., a privately held medical malpractice insurance and consulting company. Ms. Chowning is a graduate of the University of California where she holds a Bachelor of Arts in Economics. She is a Certified Public Accountant in California and a member of the American Institute of Certified Public Accountants. She joined the Board of Directors as a Class III Director effective July 24, 2008.

Board Member
Roger C. Colman

Roger C. Colman, is Vice President of Corporate Development and M&A for Alticor Corporate Enterprises Inc. (“ACE”), a member of the Alticor family of companies. He joined Alticor in 1994 and has held numerous positions, most recently overseeing corporate acquisitions. Previously, Mr. Colman assisted Amway affiliate operations in over 30 countries in diverse roles which included business process improvement and strategic planning. Prior to joining Alticor, Mr. Colman held positions as an operations and distribution executive with Readi-Bake, Inc. Mr. Colman serves on the corporate boards of Houston-based Gurwitch Products, Metagenics Inc. in San Clemente, California, and Kindex Thereapeutics LLC based in Seattle, Washington. Mr. Colman received a Bachelor of Science degree and a Master’s of Business Administration degree from Grand Valley State University in Allendale, Michigan. He joined the Board of Directors as a Series A Director effective March 11, 2011.

Board Member
Thomas R. Curran, Jr

Thomas R. Curran, Jr. is the Associate General Counsel/Corporate Development and Commercial Transactions of Alticor Inc., a company engaged in the principal business, through its affiliates, of offering products, business opportunities, and manufacturing and logistics services in more than 80 countries and territories worldwide, and which is the parent of Pyxis Innovations, Inc. He has held this position for the past seven years. He also holds the position of Chief Legal Officer for Access Business Group LLC, a manufacturing and distribution company and wholly owned subsidiary of Alticor Inc. Prior to joining Alticor, Mr. Curran was a partner in the law firm of Howard & Howard in Bloomfield Hills, Michigan. From 1982 to 1991, Mr. Curran worked for the Polaroid Corporation in various domestic and international financial and managerial positions. Mr. Curran holds a Bachelor of Arts from Providence College, a Master of International Management from the American Graduate School of International Management, and a Juris Doctorate from Suffolk University Law School. He joined the Board of Directors as a Series A Director effective March 24, 2003.

Board Member
Goran Jurkovic, CPA

Mr. Jurkovic is senior vice president and chief financial officer for Delta Dental of Michigan. Prior to that, he served as controller, where he has overseen the organization’s financial operations since 2004. Mr. Jurkovic began his career at Delta Dental in 1999 and was responsible for directing the operations of the Accounting and Finance department. Before joining Delta Dental, Mr. Jurkovic was an audit associate with Plante & Moran, PLLC, a public accounting firm headquartered in Southfield, Michigan. He received a Bachelor’s degree in accounting from Michigan State University and became a certified public accountant in 1996. He is a member of the American Institute of Certified Public Accountants and the Michigan Association of Certified Public Accountants. He joined the Board of Directors as a Series B Director effective June 29, 2012.

Board Member
William C. Mills III

William C. Mills III is currently an independent venture capitalist with over 29 years of experience in venture capital. From 2004 until 2009, Mr. Mills was a managing member of a management company conceived by EGS Healthcare Capital Partners to manage EGS Private Healthcare Partnership III. Earlier, Mr. Mills was a Partner in the Boston office of Advent International, a private equity and venture capital firm, for five years. At Advent, he was co-responsible for healthcare venture capital investments and focused on investments in the medical technology and biopharmaceutical sectors. Before joining Advent, Mr. Mills spent more than 11 years with the Venture Capital Fund of New England where he was a General Partner. Prior to that, he spent seven years at PaineWebber Ventures/Ampersand Ventures as Managing General Partner. Currently, he is a member of the Board of Managers of Ascension Health Ventures. Mr. Mills received his A.B. in Chemistry, cum laude, from Princeton University, his S.M. in Chemistry from the Massachusetts Institute of Technology and his M.S. in Management from MIT’s Sloan School of Management. Mr. Mills currently serves on the Board of Directors of Stereotaxis, Inc., a publicly traded medical device company. Mr. Mills. joined the Board of Directors on April 30, 2010.